|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-5-15
|
|
pubmed:abstractText |
Change in a patient's condition is expressed as a percentage of the baseline value for a core set of measures in the American College of Rheumatology (ACR) improvement criteria for rheumatoid arthritis (RA), and this is used as the basis to decide whether a patient has improved. The result is dependent on whether the underlying measure has a score that increases or decreases on improvement. We examined the importance of this effect in the application of the ACR improvement criteria.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1052-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11352236-Anti-Inflammatory Agents,
pubmed-meshheading:11352236-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:11352236-Antirheumatic Agents,
pubmed-meshheading:11352236-Arthritis, Rheumatoid,
pubmed-meshheading:11352236-Humans,
pubmed-meshheading:11352236-Methotrexate,
pubmed-meshheading:11352236-Prednisolone,
pubmed-meshheading:11352236-Rheumatology,
pubmed-meshheading:11352236-Severity of Illness Index,
pubmed-meshheading:11352236-Sulfasalazine,
pubmed-meshheading:11352236-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
American College of Rheumatology criteria for improvement in rheumatoid arthritis should only be calculated from scores that decrease on improvement.
|
|
pubmed:affiliation |
Department of Clinical Epidemiology & Biostatistics, Free University Hospital, Amsterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
